BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22425199)

  • 1. Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue.
    Greve T; Schmidt KT; Kristensen SG; Ernst E; Andersen CY
    Fertil Steril; 2012 Jun; 97(6):1394-8.e1. PubMed ID: 22425199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
    Binder H; Strick R; Zaherdoust O; Dittrich R; Hamori M; Beckmann MW; Oppelt PG
    Fertil Steril; 2012 May; 97(5):1169-75.e1. PubMed ID: 22401810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
    Seifer DB; Tal O; Wantman E; Edul P; Baker VL
    Fertil Steril; 2016 Feb; 105(2):385-93.e3. PubMed ID: 26515380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryobiology in human assisted reproductive technology. Would Hippocrates approve?
    Bredkjaer HE; Grudzinskas JG
    Early Pregnancy (Cherry Hill); 2001 Jul; 5(3):211-3. PubMed ID: 11753534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.
    Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ
    Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.
    Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M
    Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
    Singer T; Barad DH; Weghofer A; Gleicher N
    Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVF outcome in patients with orthotopically transplanted ovarian tissue.
    Dolmans MM; Donnez J; Camboni A; Demylle D; Amorim C; Van Langendonckt A; Pirard C
    Hum Reprod; 2009 Nov; 24(11):2778-87. PubMed ID: 19671623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients.
    Kim SS; Lee WS; Chung MK; Lee HC; Lee HH; Hill D
    Fertil Steril; 2009 Jun; 91(6):2349-54. PubMed ID: 18675964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
    Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
    Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth.
    Meirow D; Levron J; Eldar-Geva T; Hardan I; Fridman E; Yemini Z; Dor J
    Fertil Steril; 2007 Feb; 87(2):418.e7-418.e15. PubMed ID: 17097653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate.
    Kalra SK; Ratcliffe SJ; Dokras A
    Fertil Steril; 2013 Jul; 100(1):208-13. PubMed ID: 23557762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age.
    Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
    Menopause; 2011 May; 18(5):521-4. PubMed ID: 21178792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negligible serum anti-müllerian hormone: pregnancy and birth after a 1-month course of an oral contraceptive, ovarian hyperstimulation, and intracytoplasmic sperm injection.
    Tocci A; Ferrero S; Iacobelli M; Greco E
    Fertil Steril; 2009 Jul; 92(1):395.e9-395.e12. PubMed ID: 19410249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.